Hiromi Nagashima

4PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 26, 2026
Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in patients with locally advanced NSCLC.

|May 14, 2025
Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901.

Shin Saito, Yosuke Kawashima, Hisashi Tanaka

|Sep 09, 2023
Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation.

Kana Watanabe, Ryota Saito, Eisaku Miyauchi

|Apr 28, 2023
A Case of Mediastinal Tuberculous Lymphadenitis in a Chronic Dialysis Patient Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA).

Hiromi Nagashima, Kazuyuki Abe, Yukihiro Owada

Pageof 1

Frequent Collaborators

2 joint publications

Shunichi Sugawara

1 joint publications

Eisaku Miyauchi

1 joint publications

Nobuyuki Tanaka

1 joint publications

Tatsuro Fukuhara